📰 Use Authorization News
Page 21 - Use Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Authorization. Real-time updates on events, politics, business and more.
May 28, 2022
Hy-Vee Inc. recently announced that COVID-19 antivirals, Molnupiravir and PAXLOVID, are now available at Hy-Vee Pharmacy locations throughout its eight-state region to help treat eligible patients who have mild-to-moderate cases
May 27, 2022
Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a molecular SARS-CoV-2 test enabling unsupervised self-collection.
May 25, 2022
SIOUX FALLS, S.D. (KELO.com) -- Hy-Vee announced today that COVID-19 antiviral drugs, Molnupiravir and PAXLOVID, are now available at Hy-Vee Pharmacy ...
May 25, 2022
Here's What it Takes To Be Eligible for Approved Covid Antivirals
May 25, 2022
In this article, we discuss the 9 stocks Masayoshi Son is selling in 2022.
May 25, 2022
Here's What it Takes To Be Eligible for Approved Covid Antivirals
May 25, 2022
Here's What it Takes To Be Eligible for Approved Covid Antivirals
May 25, 2022
SIOUX FALLS, S.D. (KELO.com) -- Hy-Vee announced today that COVID-19 antiviral drugs, Molnupiravir and PAXLOVID, are now available at Hy-Vee Pharmacy ...
May 23, 2022
U.S. health officials are urging a booster shot of Pfizer's COVID-19 vaccine for kids ages 5 to 11 and the CDC has quickly signed off on the advice.
May 20, 2022
U.S. health officials are urging a booster shot of Pfizer's COVID-19 vaccine for kids ages 5 to 11 and the CDC has quickly signed off on the advice.